Yesterday, Alcon was alerted that our third quarter earnings press ... In vitreoretinal advancements, this new technology provides up to 1.5 times faster vitrectomy with cutting speeds of up to 30,000 ...

According to Research by S&S Insider, The Vitrectomy Devices Market Growth is Driven by Rising Diabetes-Related Retinal Conditions and Technological Advances.Austin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ...

In addition, Alcon presents pivotal data for AR-15512 (acoltremon 0.003%)*, a prescription drug candidate undergoing FDA review for the treatment of dry eye FORT WORTH, Texas, October 15 ...

Vitrectomy packs improve surgical efficiency ... Recent Developments in the Retinal Surgery Market In July 2024, Alcon Inc. announced the acquisition of Belkin Vision to strengthen its glaucoma ...

This year’s expo highlights a wide array of health and wellness products for the elderly, from therapeutic treatments to ...

This year, Alcon, the global eyecare leader, presents a robust lineup at CIIE (from November 5th to 10th ), featuring one latest innovation and four Chinese debuts, covering its product excellence ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY ...

Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon introduces new handheld gas delivery systems, UNIFEYE and ...

In addition, Alcon presents pivotal data for AR-15512 (acoltremon 0.003%)*, a prescription drug candidate undergoing FDA review for the treatment of dry eye FORT WORTH, Texas, October 15, ...